<DOC>
	<DOCNO>NCT02776267</DOCNO>
	<brief_summary>The purpose study perform first-in-man assessment feasibility , exploratory efficacy clinical performance novel Angiolite drug-eluting stent ( iVascular , Barcelona , Spain ) utilize intracoronary optical coherence tomography ( OCT ) .</brief_summary>
	<brief_title>Percutaneous Coronary Intervention With Angiolite Drug-eluting Stent : Optical Cohenrece Tomography Study</brief_title>
	<detailed_description>This prospective registry include patient schedule clinically-indicated percutaneous coronary intervention ( PCI ) de novo epicardial lesion indication drug-eluting stent implantation . Following study enrolment PCI/stent Angiolite DES , patient schedule follow-up surveillance coronary angiography OCT C7-XRTM Fourier Domain OCT system C7 DragonflyTM catheter ( St Jude Medical , Minneapolis , MN ) Terumo LunawayTM OCT system fastview catheter ( Terumo Medical Corporation , Tokyo , Japan ) . An adaptive design component study randomize patient either 3-month 6-month angio/OCT follow-up . Clinical follow-up occur 30 day , 3 month , 6 month , 12 month 24 month post PCI .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>Patients schedule clinicallyindicated PCI de nove epicardial lesion , include chronic stable angina , ACS ( define NSTEMI ACS negative cardiac enzyme ) set elective PCI . Indication DES implantation Target lesion must visually estimate stenosis ≥50 % one following : stenosis ≥70 % evidence ischemia Strong preference single stent coverage per lesion , unexpected clinically indicated second stent placement overlap need , patient exclude optical coherence tomographic followup Target lesion , possible , predilated/pretreated Age &gt; 85 year Acute ST segment elevation MI ( STEMI ) Cardiogenic shock Known leave ventricular ejection fraction &lt; 30 % Contraindication dual antiplatelet therapy ( DAPT ) least 6month duration Iodinated contrast allergy Renal impairment serum creatinine &gt; 2.0 mg/dL Anticipated medical noncompliance Lifeexpectancy &lt; 12 month Chronic total occlusion ( CTO ) target vessel Bifurcation lesion require twostent strategy Instent restenosis Severe lesion/segment angulation/tortuosity Severe vessel/lesion calcification Simultaneous PCI within different vessel procedure Lesion unsuitable OCT ( proximal lesion &lt; 10 mm ostium leave main right coronary artery ) Lesion length &gt; 18 mm Stent length &gt; 24 mm Stent diameter ≤2.5 mm &gt; 4.0 mm Unprotected leave main coronary artery disease ( ≥50 % diameter stenosis ) &gt; 1 lesion Planned use 2 overlap stent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>